Rheumatology patients need continuous monitoring and regular lab draws — the intensive relationship a direct-care membership is built for. Here's how the practice model works.
Rheumatology patients don't leave. A patient with rheumatoid arthritis, lupus, or psoriatic arthritis is with you for years — often decades — and needs consistent monitoring, regular lab draws, and access between visits. That clinical relationship, and the intensity it demands, is exactly what a direct-care membership is built for.
Insurance reimbursement models pay for encounters, not relationships. For a rheumatologist managing complex chronic patients, the economics don't work: the time required to monitor inflammatory markers, adjust biologics, and respond to flares cannot be compressed into a 15-minute slot without compromising care. Direct care removes that constraint.
Rheumatoid arthritis patients require, by current clinical consensus, monthly visits during active disease adjustment. A systematic review published in Arthritis Care & Research found that US rheumatologists averaged 5.25 visits per patient per year — and treat-to-target protocols call for monthly monitoring during DMARD titration.
Lupus is more variable but often more intensive. Disease activity monitoring requires regular CBC, comprehensive metabolic panels, complement levels, and dsDNA antibody titers — multiple lab draws per quarter. Psoriatic arthritis adds imaging considerations alongside inflammatory and metabolic panels, particularly for patients on biologics requiring hepatic monitoring.
These patients don't fit a high-volume, low-touch practice. They fit a membership — and the direct-care model is increasingly how rheumatologists are responding to that reality. The same structural fit is driving specialist practices across disciplines; see how cardiologists and neurologists are structuring direct-care practices built around long visits and complex patients.
Prior authorization for biologics is the most-cited specialty-specific driver of rheumatologist burnout. A survey of physicians found that 93% report prior authorization delays patient care and 89% link it to burnout — with the average physician completing 39 prior authorizations per week and spending 13 hours on the process. In rheumatology, where the most effective treatments are often the most expensive, biologics sit at the center of nearly every dispute.
The result is a specialty where the patients who most need continuous care are the ones most often interrupted by administrative barriers. Direct care removes prior authorization from the equation: the practice sets its own access terms, and the clinical relationship continues without interruption.
Visit structure in specialist direct care differs from primary-care DPC. Rheumatology visits typically run 45 to 60 minutes for an established patient, with thorough history review and joint examination. Panel sizes are smaller than primary care — a rheumatologist managing complex inflammatory disease can follow several hundred members at the same clinical depth a high-volume insurance practice can't approach.
Lab cadence is the defining operational characteristic. A patient on methotrexate needs CBC and hepatic function panels every 8 to 12 weeks. A patient starting a biologic may need monthly labs until stable, then quarterly. Lupus patients in a flare may need weekly monitoring. In a direct-care practice, the physician sets that schedule and follows through without step-therapy delays or insurer approval.
Membership pricing for rheumatology reflects the visit length and lab intensity. Most structures cover ongoing physician access, included secure messaging between visits, and a defined number of visits per period — additional visits priced separately or included in a higher-tier plan. The specifics depend on the patient mix and how much clinical access the practice is designed to provide.
In SigmaMD, lab ordering lives inside the patient chart. From the chart view, the physician clicks "Order labs," selects a diagnostic provider, and builds the order — adding individual tests or pulling from a custom panel the practice has already configured.
The most efficient setup for a rheumatology practice is a set of named monitoring panels for the most common combinations: a methotrexate monitoring panel, an RA baseline panel, a lupus disease-activity panel. In SigmaMD, lab test panels are built per diagnostic provider — name the panel, select the provider, add the tests, and it's available at the point of ordering. The practice builds its own panels around its clinical workflow; the platform makes a recurring order a single selection instead of reconstructing it from scratch each visit.
SigmaMD supports three billing paths for lab orders: Pay in Clinic (the practice pays the lab and collects from the patient), Use Insurance (the lab bills the patient's insurer directly), and Pay at PSC (the patient pays at the Patient Service Center). A practice operating outside insurance will run most orders on Pay in Clinic or Pay at PSC. The full lab ordering guide covers each path in detail.
Rheumatology patients have questions between visits. A patient starting a new biologic may have injection site concerns. A lupus patient waking up with new joint swelling wants to know whether to come in. These are not scenarios that resolve with a voicemail.
SigmaMD's secure messaging is built into the patient chart and accessible to patients through the SigmaMD Patient App. Messages are end-to-end encrypted, routed to the patient's chart thread, and trigger SMS notifications if unanswered — so urgent messages don't fall through a gap. The physician can respond from the chart or from the clinician mobile app; the conversation stays organized in the record rather than scattered across a separate portal.
For visit documentation, SigmaMD Scribe captures notes via voice recording. The practice builds its own note templates and snippets in the template editor — a rheumatology practice may set up a flare-visit template, a joint-exam template, and a new-patient rheumatology intake template. Scribe maps its output to whichever template is active at the start of the visit, without a separate login or copy-pasting step.
For chart review, Sigma AI — currently in beta — lets the physician query a patient's chart in plain language: "What were this patient's last three CRP values?" or "What biologics has this patient been on?" Sigma AI retrieves chart information and can suggest ICD-10 codes based on clinical context, reducing the time spent clicking through a chart before responding to a between-visit message.
In an insurance-based practice, the biologic conversation is often administrative before it is clinical: which agents will the insurer approve, in what sequence, and after how many step-therapy failures. The physician frequently can't prescribe the most appropriate treatment until a payer agrees.
In a direct-care practice, that conversation is purely clinical. The physician and patient decide together — based on disease activity, tolerance, and cost — without a payer in the middle. For patients managing conditions like RA and lupus, where the difference between the right biologic and the approved biologic can be clinically significant, that shift matters. This is the clearest argument for why complex chronic patients — the ones who most need their physician's judgment to be the final word — are better served outside insurance.
Both work. Some rheumatologists operate fully outside insurance; others retain one payer or Medicare while building a direct-care panel alongside. A hybrid practice lets a physician test the model without immediately exiting all insurance contracts.
The direct-care practice handles coordination — ordering imaging, writing referral letters, communicating results — but the specialist or facility bills separately. The membership covers the rheumatologist's time and access; it doesn't bundle the entire care episode.
Most practices recommend patients carry a high-deductible health plan or similar coverage for hospitalizations, specialist procedures, and medications. The membership covers ongoing rheumatologist access; it is not a replacement for catastrophic coverage.
This varies by practice. Some facilitate access to manufacturer patient assistance programs; others work with compounding pharmacies for appropriate medications. The membership itself typically does not cover biologic costs — those are negotiated separately between the patient and the pharmacy or program.
Ready to see how a rheumatology practice runs on SigmaMD? Book a demo.
A 30-minute walkthrough to review your workflow in SigmaMD and answer your questions.
Book a demo